Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

Delayed Data
As of 11:26am ET
 -0.025 / -0.17%
Today’s Change
Today|||52-Week Range
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
11:20am / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for...
Nov 30 / Zacks.com - Paid Partner Content
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar
Nov 30 / GuruFocus News - Paid Partner Content
What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?
Nov 29 / MotleyFool.com - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
Teva's Leukemia Drug Gets EU Approval in First-Line Setting
Nov 22 / Zacks.com - Paid Partner Content
Company News for November 30, 2016
Nov 30 / Zacks.com - Paid Partner Content